It is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies
oleh: Caroline Besson
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2021-07-01 |
Deskripsi
No description available for this item.